Lowenthal Richard E

Lowenthal Richard E is listed in filings as PRESIDENT AND CEO at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY). The current snapshot covers public activity from Jun 13, 2024 to Jan 5, 2026. Reported amounts are shown as $437.5K to $439.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.